Creative Medical Technology Holdings Inc (CELZ) - Total Liabilities
Based on the latest financial reports, Creative Medical Technology Holdings Inc (CELZ) has total liabilities worth $698.60K USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Creative Medical Technology Holdings Inc to evaluate the company's liquid asset resilience ratio.
Creative Medical Technology Holdings Inc - Total Liabilities Trend (2006–2025)
This chart illustrates how Creative Medical Technology Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc Competitors by Total Liabilities
The table below lists competitors of Creative Medical Technology Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Elite Education Group International Ltd
NASDAQ:EEIQ
|
USA | $8.39 Million |
|
APOLLO GROUP-A
F:APO
|
Germany | €1.28 Million |
|
POMDOCTOR LIMITED American Depositary Shares
NASDAQ:POM
|
USA | $588.85 Million |
|
BetterLife Pharma Inc
F:NPAU
|
Germany | €6.04 Million |
|
Dongil Technology Ltd
KQ:032960
|
Korea | ₩3.59 Billion |
|
Adalta Ltd
AU:1AD
|
Australia | AU$2.07 Million |
|
Avada Group Ltd
AU:AVD
|
Australia | AU$70.73 Million |
|
Lianhe Sowell International Group Ltd Ordinary Shares
NASDAQ:LHSW
|
USA | $27.02 Million |
Liability Composition Analysis (2006–2025)
This chart breaks down Creative Medical Technology Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Creative Medical Technology Holdings Inc (CELZ) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 12.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Creative Medical Technology Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Creative Medical Technology Holdings Inc (2006–2025)
The table below shows the annual total liabilities of Creative Medical Technology Holdings Inc from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $284.88K | -13.05% |
| 2024-12-31 | $327.64K | -11.78% |
| 2023-12-31 | $371.39K | -88.82% |
| 2022-12-31 | $3.32 Million | +216.21% |
| 2021-12-31 | $1.05 Million | -97.41% |
| 2020-12-31 | $40.52 Million | +371.05% |
| 2019-12-31 | $8.60 Million | +92.37% |
| 2018-12-31 | $4.47 Million | +83.32% |
| 2017-12-31 | $2.44 Million | +407.87% |
| 2016-12-31 | $480.30K | +161.01% |
| 2015-12-31 | $184.02K | +19.50% |
| 2014-12-31 | $154.00K | +22.80% |
| 2013-12-31 | $125.41K | +26.27% |
| 2012-12-31 | $99.32K | +31.95% |
| 2011-12-31 | $75.27K | +55.12% |
| 2010-12-31 | $48.52K | +43.02% |
| 2009-12-31 | $33.93K | +4454.09% |
| 2008-12-31 | $745.00 | -91.97% |
| 2007-12-31 | $9.28K | +9.90% |
| 2006-12-31 | $8.45K | -- |
About Creative Medical Technology Holdings Inc
Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DD… Read more